7/21/2025ZimVie shares catapulted by triple digits Monday after the dental... BREAKING: Stocks Bounce But Tumble For Week The Relative Strength (RS) Rating for Solventum (SOLV) stock jumped into a higher percentile Friday, as it got a lift from 70 to 78. Â How To Invest In Stocks In Both Bull And Bear Markets This exclusive rating from Investor's Business Daily identifies market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's… Related news ZimVie Doubles — And Then Some — On It ...

Core Insights - Global equity markets experienced significant growth in Q3, with the S&P 500 rising 8.12% for the quarter and 14.83% year-to-date, while the MSCI EAFE Index increased by 4.77% for the quarter and 25.14% year-to-date [2][3] Market Performance - The S&P 500 achieved back-to-back annual returns of 26% and 25% in 2023 and 2024, respectively, with valuation metrics like the "Buffett Indicator" and CAPE-Shiller P/E at or near record highs [2] - Non-US equities, particularly European stocks, outperformed the S&P 500 year-to-date, benefiting from a weaker US dollar and a resurgence in value recognition [3][11] Fund Performance - Tweedy, Browne Funds reported year-to-date returns ranging from 15.98% for the Value Fund to 23.17% for the International Value Fund II, with the Worldwide High Dividend Yield Value Fund outperforming its benchmark [3][5] - The International Value Fund II had a return of 23.17%, trailing its benchmark, the unhedged MSCI EAFE Index, by 197 basis points [3] Portfolio Activity - The company made strategic adjustments to its portfolio, trimming or selling holdings that reached estimated value and adding to companies perceived as attractively priced, such as Berkeley Group Holdings and Breedon Group [8] - New positions were initiated in Santec Holdings and additional investments were made in companies like Dentium and Azelis Group, reflecting a focus on growth potential and reasonable valuations [8] Outlook - The company is optimistic about the resurgence of non-US equity returns and believes its funds are well-positioned for future market conditions, whether they favor non-US equities or face broader market challenges [11]

Core Points - ZimVie Inc. will report its financial results for Q2 2025 on July 30, 2025, after market close [1] - ZimVie has entered into a definitive agreement to be acquired by an affiliate of ARCHIMED for $19.00 per share in cash [2] - The acquisition is expected to close by the end of 2025, pending stockholder and regulatory approvals [3] Company Overview - ZimVie is a global leader in the dental implant market, focusing on developing and delivering products for dental tooth replacement and restoration [4] - The company aims to enhance smiles, function, and confidence through its comprehensive portfolio, which includes dental implants, biomaterials, and digital workflow solutions [4] Transaction Details - Upon completion of the acquisition, ZimVie will become a privately held company, and its shares will no longer be traded on NASDAQ [3] - Due to the pending acquisition, ZimVie will not hold a conference call for Q2 and has withdrawn its fiscal 2025 guidance [3]

Core Insights - ZimVie Inc. has entered a strategic distribution agreement with Osstem Implant Co., Ltd. to enhance its presence in the growing Chinese dental implant market, which is estimated to exceed 10 million units annually [1][2] Company Overview - ZimVie is a global leader in the dental implant market, focusing on developing and delivering a comprehensive portfolio of products for dental tooth replacement and restoration [5] - Osstem Implant, founded in 1997, is the largest dental implant manufacturer globally and a leading provider in the Asia-Pacific region, with a strong distribution network in over 90 countries [6] Market Dynamics - The partnership allows ZimVie to leverage Osstem's established distribution channels and clinical training programs, enhancing customer access to ZimVie's innovative implant portfolio [2][4] - Osstem Implant has built a robust presence in over 90 cities in China and conducts nearly 500 clinical training sessions annually, which strengthens its market position [2] Strategic Benefits - The collaboration is expected to provide a wider product selection for dental professionals and patients, enhancing the overall customer experience [4] - ZimVie's premium implants are designed for precision, aesthetics, and durability, aligning with the company's commitment to innovation and global expansion [4]

Core Insights - ZimVie Inc. has launched its RealGUIDE Software Suite and Implant Concierge service in Japan, enhancing access to a digital dental implant ecosystem [1][2] - The Japanese dental implant market is significant, representing ZimVie's largest market in the APAC region [1] Product Offerings - RealGUIDE software provides comprehensive tools for precise implant planning, surgical guides, and restorative design, aimed at improving patient care and operational efficiencies [2] - The software is the first complete cloud-based solution of its kind, consisting of multiple modules for thorough diagnosis and advanced design [2] - Implant Concierge is a virtual outsourcing service that simplifies implant treatment planning and guided surgery, designed for high-volume practices [3] Market Opportunity - The rising adoption of dental implants presents a substantial growth opportunity, necessitating more efficient and integrated treatment workflows [4] - Digital dentistry is becoming the new standard in implantology, with ZimVie experiencing strong traction in other markets [4]

Core Viewpoint - ZimVie Inc. has launched its Immediate Molar Implant System in the United States, enhancing its existing TSX and T3 PRO Implant systems to address the complexities of molar tooth restoration, thereby reducing treatment times and improving patient outcomes [1][4]. Group 1: Product Features - The Immediate Molar Implant System includes specially engineered instrumentation that simplifies site preparation during molar extraction, making the procedure more controlled and predictable [2]. - The system features optimized wide-diameter implants that enhance primary stability and potentially reduce the risk of peri-implantitis by up to 20% through proprietary DAE coronal surface technology [2]. - Compared to conventional treatment protocols, the Immediate Molar Implant System allows for restoration in half the time, streamlining the overall treatment process [3]. Group 2: Company Commitment - The launch of the Immediate Molar Dental Implant System represents a significant milestone in ZimVie's commitment to advancing dental technology, aiming to provide shorter and more cost-effective treatment options while ensuring predictable and lasting outcomes for patients [4]. - ZimVie has a history of developing products like the TSX and T3 PRO Implants, which are designed for immediate extraction and loading protocols, ensuring placement predictability and primary stability [5][8]. Group 3: Market Position - ZimVie is positioned as a global leader in the dental implant market, focusing on comprehensive solutions for dental tooth replacement and restoration procedures, with a commitment to improving clinical science and technology [10].